

CAS No:1012341-50-2
MF:C23H29NO4
Appearance:white or off-white crystalline powder
Specification:98.5%
UN number:-
Package:1/5/10/25kgs/drum
Supply Capacity:Tons
Synonyms:(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid;LCZ696 inter.;LCZ-696-001-SS;LCZ696-24;(2R,4S)-5-(4-Biphenylyl)-4-(Boc-amino)-2-methylpentanoic Acid;(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl) amino]-2-methylpentanoic acid AHU84;(2R, 4S) -5- (biphenyl-4-yl) -4-[(tert-butoxycarbonyl) amino] -2-methylvaleric acid;LCZ696S-01,"(2R,4S)-2-methyl-4-((2-methylpropan-2-yl)oxycarbonylamino)-5-(4-phenylphenyl)pentanoic acid","(2R,4S)-2-methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-(4-phenylphenyl)pentanoic acid; (2R,4S)-2-methyl-4-((2-methylpropan-2-yl)oxycarbonylamino)-5-(4-phenylphenyl)pentanoic acid; 695-674-1; 1012341-50-2; (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid; (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid; (2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methylpentanoic acid; MFCD27955981; FJ7AWX8DMF; [1,1'-Biphenyl]-4-pentanoic acid, gamma-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-methyl-, (alphaR,gammaS)-; (2R,4S)-5-((1,1'-Biphenyl)-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid; (2R,4S)-5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid; C23H29NO4; 5-((1,1'-Biphenyl)-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid, (2R,4S)-; YNELJETWNMPEEH-UZLBHIALSA-N; (1,1'-Biphenyl)-4-pentanoic acid, gamma-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-methyl-, (alphaR,gammaS)-; (alphaR,gammaS)-gamma-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-methyl[1,1'-biphenyl]-4-pentanoic Acid;; UNII-FJ7AWX8DMF; LCZ-696 Intermediate 40; SCHEMBL597902; DTXSID001123526; AKOS027324883; AC-28990; DS-11562; SY116136; DB-335942; CS-0009331; (2R,4S)-5-(4-Biphenylyl)-4-(Boc-amino)-2-methylpentanoic Acid; (2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pentanoic acid; (2R,4S)-4-(tert-butoxycarbonylamino)-2-methyl-5-(4-phenylphenyl)pentanoic acid; (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoicacid; (1,1'-BIPHENYL)-4-PENTANOIC ACID, .GAMMA.-(((1,1-DIMETHYLETHOXY)CARBONYL)AMINO)-.ALPHA.-METHYL-, (.ALPHA.R,.GAMMA.S)-; (I+/-R,I(3)S)-I(3)-[[(1,1-Dimethylethoxy)carbonyl]amino]-I+/--methyl[1,1a(2)-biphenyl]-4-pentanoic acid; [1,1'-Biphenyl]-4-pentanoic acid, ; A-[[(1,1-dimethylethoxy)carbonyl]amino]-; A-methyl-, (; AR,; AS)-",383.500,C23H29NO4,
Product application:1012341-50-2, (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid, Sacubitril Intermediate, Boc-L-Tyrosine derivative, AHU-377 Intermediate, LCZ696 raw material, 2-Methyl-4-Boc-amino-5-biphenylpentanoic acid, pharmaceutical grade intermediates, pharmaceutical manufacturing, CAS 1012341-50-2 factory price, high purity chemical reagents, cardiovascular drug intermediates, chemical synthesis, Suzhou Health Chemicals export.
(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid serves as a vital chiral intermediate for the synthesis of Sacubitril, a key component of the blockbuster heart failure medication LCZ696. With two chiral centers in its structure, its stereoisomeric purity is essential for the yield and quality of the final API. It is primarily used in the pharmaceutical industry for building the molecular framework of neprilysin inhibitors.